MetaCap

Who Owns Oragenics Stock?

NYSE: OGENHealthcareBiotechnologyUSD

0.463-0.0369 (-7.38%)

At close: Oct 8, 3:59 PM ET · Delayed 15 min

Ownership breakdown

Held by institutions
3.06%
Institutional holders
20
  • Institutions 3.1%
  • Insiders 1.9%
  • Public and other 95.0%

Who owns Oragenics stock?

Institutional investors own about 3.1% of Oragenics's shares, spread across 20 institutions that file 13F reports. That level of institutional ownership is relatively low, leaving more of the stock with retail investors and insiders. Insiders, including executives, directors and large founding shareholders, hold 1.93% of OGEN.

The largest institutional holders are Geode Capital Management, LLC (0.52%), 25 LLC (0.51%) and Jane Street Group, LLC (0.28%). Together, the top 10 institutions control 1.5% of shares outstanding. In their latest filings, 4 of the top 10 institutions increased their OGEN positions and 2 reduced them.

Summary generated from market data by MetaCap's automated system. Methodology

Top institutional holders of OGEN

Oragenics top institutional holders
InstitutionShares% HeldChange
Geode Capital Management, LLC23.68K0.52%-63.6%
25 LLC 23.16K0.51%+100.0%
Jane Street Group, LLC12.77K0.28%+100.0%
Tower Research Capital LLC (TRC)4.55K0.10%0.0%
St. Johns Investment Management Company, LLC1.92K0.04%+862.0%
Blackrock Inc.7030.02%0.0%
UBS Group AG6420.01%-87.7%
Harbour Investments, Inc.340.00%0.0%
Wells Fargo & Company340.00%0.0%
SBI Securities Co., Ltd.230.00%+109.1%

% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.

Top mutual fund and ETF holders of OGEN

Oragenics top fund holders
FundShares% Held
Fidelity Concord Street Trust-Fidelity Extended Market Index Fund22.39K0.50%

Frequently asked questions

Who is the largest shareholder of Oragenics?

Geode Capital Management, LLC is the largest institutional shareholder of OGEN, owning 0.52% of shares outstanding (23.68K shares) as of its latest 13F filing.

What percentage of Oragenics is owned by institutions?

Institutions own about 3.1% of OGEN shares and 3.1% of the public float.

How much of Oragenics do insiders own?

Insiders, such as officers and directors, own about 1.93% of OGEN shares outstanding.

Where does institutional ownership data come from?

Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.

Related